Drug
Decitabine
Decitabine: highest development phase Phase 2, developed by Eisai, United Therapeutics. 3 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Eisai, United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Decitabine NCT00561912 | Phase 2 | Renal Cell Carcinoma |
| decitabine (5-aza-2'deoxycytidine) NCT00041990 | Phase 2 | Chronic Myelogenous Leukemia |
| Decitabine, LBH589, Tamoxifen NCT01194908 | Phase 1/2 | Breast Cancer |
Latest
No recent events.
Follow Decitabine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.